A detailed history of Hein Park Capital Management LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Hein Park Capital Management LP holds 1,853,579 shares of BHC stock, worth $17.1 Million. This represents 75.81% of its overall portfolio holdings.

Number of Shares
1,853,579
Previous 1,653,579 12.09%
Holding current value
$17.1 Million
Previous $17.5 Million 26.36%
% of portfolio
75.81%
Previous 76.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $1.22 Million - $2.08 Million
200,000 Added 12.09%
1,853,579 $12.9 Million
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $4.66 Million - $6.37 Million
600,000 Added 56.95%
1,653,579 $17.5 Million
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $6.88 Million - $8.67 Million
1,053,579 New
1,053,579 $8.45 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Hein Park Capital Management LP Portfolio

Follow Hein Park Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hein Park Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hein Park Capital Management LP with notifications on news.